Annaly Capital Management, Inc. vs Nuwellis Inc — how do they compare? Annaly Capital Management, Inc. trades at $23.21 (market cap $17.27B), while Nuwellis Inc trades at $1.49 (market cap $522.76K). The key difference: Annaly Capital Management, Inc. is far larger — about 33036.2× Nuwellis Inc's market cap, and Annaly Capital Management, Inc. pays a 13.09% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NLY | NUWE | |
|---|---|---|
Market Cap | $17.27B | $522.76K |
Sector | Financials | Technology |
52-Week High | $24.40 | $220.50 |
52-Week Low | $20.21 | $1.42 |
Dividend Yield | 13.09% | — |
Enterprise Value | — | -$1.29M |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →